Trestle Biotherapeutics announces license agreement with Kumamoto University for key stem cell biology technology for regenerative medicine
Trestle gains access to pioneering kidney stem cell biology differentiation protocols
Trestle gains access to pioneering kidney stem cell biology differentiation protocols
The new Mix-n-Stain Antibody Labeling Kits offer an optimal low degree of labeling with your choice of Biotium’s superior CF Dyes for STORM
Proteomics breakthrough reveals promising drug candidates for cystic fibrosis therapy
The company’s FDA-cleared imaging and AI analysis platforms promise to enhance diagnostic capabilities and enable remote work
All new TSI BioTrak instruments from Validair feature an enhanced algorithm for more rigorous validation
New mass photometer promises rapid, autonomous, and label-free mass characterisation of biomolecules at the single-molecule level
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on in situ material testing, plastic materials, and proteomics
The latest news and technological innovations from SLAS2022 International Conference and Exhibition
Eftilagimod alpha, a soluble LAG-3 fusion protein is a first-in-class antigen presenting cell activator currently being explored in cancer and infectious disease